Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(23 sites)
United States
HonorHealth, Scottsdale, Arizona University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla, California South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan NYU Langone Health - Long Island, Mineola, New York New York University (NYU) Clinical Cancer Center, New York, New York